Global ?-Nicotinamide Mononucleotide (NMN) Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
The global ?-Nicotinamide Mononucleotide (NMN) market size is projected to grow from US$ 401 million in 2024 to US$ 763 million in 2030; it is expected to grow at a CAGR of 11.3% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “?-Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world ?-Nicotinamide Mononucleotide (NMN) sales in 2023, providing a comprehensive analysis by region and market sector of projected ?-Nicotinamide Mononucleotide (NMN) sales for 2024 through 2030. With ?-Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ?-Nicotinamide Mononucleotide (NMN) industry.
This Insight Report provides a comprehensive analysis of the global ?-Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ?-Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ?-Nicotinamide Mononucleotide (NMN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ?-Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ?-Nicotinamide Mononucleotide (NMN).
Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ?98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.
This report presents a comprehensive overview, market shares, and growth opportunities of ?-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global ?-Nicotinamide Mononucleotide (NMN) market?
What factors are driving ?-Nicotinamide Mononucleotide (NMN) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do ?-Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?
How does ?-Nicotinamide Mononucleotide (NMN) break out by Type, by Application?
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
The global ?-Nicotinamide Mononucleotide (NMN) market size is projected to grow from US$ 401 million in 2024 to US$ 763 million in 2030; it is expected to grow at a CAGR of 11.3% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “?-Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world ?-Nicotinamide Mononucleotide (NMN) sales in 2023, providing a comprehensive analysis by region and market sector of projected ?-Nicotinamide Mononucleotide (NMN) sales for 2024 through 2030. With ?-Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ?-Nicotinamide Mononucleotide (NMN) industry.
This Insight Report provides a comprehensive analysis of the global ?-Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ?-Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ?-Nicotinamide Mononucleotide (NMN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ?-Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ?-Nicotinamide Mononucleotide (NMN).
Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ?98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.
This report presents a comprehensive overview, market shares, and growth opportunities of ?-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Content ?98%
- Content ?98%
- Health Care Products
- Cosmetics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GeneHarbor
- Herbalmax
- Genex Formulas
- Mirailab Bioscience
- Maac10 Formulas
- EffePharm
- Bontac
- CELFULL
- Kingdomway
What is the 10-year outlook for the global ?-Nicotinamide Mononucleotide (NMN) market?
What factors are driving ?-Nicotinamide Mononucleotide (NMN) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do ?-Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?
How does ?-Nicotinamide Mononucleotide (NMN) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for ?-Nicotinamide Mononucleotide (NMN) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for ?-Nicotinamide Mononucleotide (NMN) by Country/Region, 2019, 2023 & 2030
2.2 ?-Nicotinamide Mononucleotide (NMN) Segment by Type
2.2.1 Content ?98%
2.2.2 Content ?98%
2.3 ?-Nicotinamide Mononucleotide (NMN) Sales by Type
2.3.1 Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
2.3.2 Global ?-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2019-2024)
2.3.3 Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024)
2.4 ?-Nicotinamide Mononucleotide (NMN) Segment by Application
2.4.1 Health Care Products
2.4.2 Cosmetics
2.4.3 Others
2.5 ?-Nicotinamide Mononucleotide (NMN) Sales by Application
2.5.1 Global ?-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
2.5.2 Global ?-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2019-2024)
2.5.3 Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global ?-Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
3.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2019-2024)
3.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
3.2 Global ?-Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2019-2024)
3.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024)
3.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
3.3 Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers ?-Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers ?-Nicotinamide Mononucleotide (NMN) Product Location Distribution
3.4.2 Players ?-Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
4.1 World Historic ?-Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2019-2024)
4.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic ?-Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2019-2024)
4.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2019-2024)
4.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region (2019-2024)
4.3 Americas ?-Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC ?-Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe ?-Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Growth
5 AMERICAS
5.1 Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Country
5.1.1 Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
5.1.2 Americas ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
5.2 Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
5.3 Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Region
6.1.1 APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024)
6.1.2 APAC ?-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024)
6.2 APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
6.3 APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe ?-Nicotinamide Mononucleotide (NMN) by Country
7.1.1 Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
7.1.2 Europe ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
7.2 Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
7.3 Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) by Country
8.1.1 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
8.1.2 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
8.2 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
8.3 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of ?-Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of ?-Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of ?-Nicotinamide Mononucleotide (NMN)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 ?-Nicotinamide Mononucleotide (NMN) Distributors
11.3 ?-Nicotinamide Mononucleotide (NMN) Customer
12 WORLD FORECAST REVIEW FOR ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
12.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
12.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Forecast by Region (2025-2030)
12.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global ?-Nicotinamide Mononucleotide (NMN) Forecast by Type (2025-2030)
12.7 Global ?-Nicotinamide Mononucleotide (NMN) Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 GeneHarbor
13.1.1 GeneHarbor Company Information
13.1.2 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.1.3 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GeneHarbor Main Business Overview
13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
13.2.1 Herbalmax Company Information
13.2.2 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.2.3 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Herbalmax Main Business Overview
13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
13.3.1 Genex Formulas Company Information
13.3.2 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.3.3 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Genex Formulas Main Business Overview
13.3.5 Genex Formulas Latest Developments
13.4 Mirailab Bioscience
13.4.1 Mirailab Bioscience Company Information
13.4.2 Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.4.3 Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Mirailab Bioscience Main Business Overview
13.4.5 Mirailab Bioscience Latest Developments
13.5 Maac10 Formulas
13.5.1 Maac10 Formulas Company Information
13.5.2 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.5.3 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Maac10 Formulas Main Business Overview
13.5.5 Maac10 Formulas Latest Developments
13.6 EffePharm
13.6.1 EffePharm Company Information
13.6.2 EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.6.3 EffePharm ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 EffePharm Main Business Overview
13.6.5 EffePharm Latest Developments
13.7 Bontac
13.7.1 Bontac Company Information
13.7.2 Bontac ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.7.3 Bontac ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bontac Main Business Overview
13.7.5 Bontac Latest Developments
13.8 CELFULL
13.8.1 CELFULL Company Information
13.8.2 CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.8.3 CELFULL ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CELFULL Main Business Overview
13.8.5 CELFULL Latest Developments
13.9 Kingdomway
13.9.1 Kingdomway Company Information
13.9.2 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.9.3 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Kingdomway Main Business Overview
13.9.5 Kingdomway Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for ?-Nicotinamide Mononucleotide (NMN) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for ?-Nicotinamide Mononucleotide (NMN) by Country/Region, 2019, 2023 & 2030
2.2 ?-Nicotinamide Mononucleotide (NMN) Segment by Type
2.2.1 Content ?98%
2.2.2 Content ?98%
2.3 ?-Nicotinamide Mononucleotide (NMN) Sales by Type
2.3.1 Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
2.3.2 Global ?-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2019-2024)
2.3.3 Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024)
2.4 ?-Nicotinamide Mononucleotide (NMN) Segment by Application
2.4.1 Health Care Products
2.4.2 Cosmetics
2.4.3 Others
2.5 ?-Nicotinamide Mononucleotide (NMN) Sales by Application
2.5.1 Global ?-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
2.5.2 Global ?-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2019-2024)
2.5.3 Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global ?-Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
3.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2019-2024)
3.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
3.2 Global ?-Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2019-2024)
3.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024)
3.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
3.3 Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers ?-Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers ?-Nicotinamide Mononucleotide (NMN) Product Location Distribution
3.4.2 Players ?-Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
4.1 World Historic ?-Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2019-2024)
4.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic ?-Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2019-2024)
4.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2019-2024)
4.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region (2019-2024)
4.3 Americas ?-Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC ?-Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe ?-Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Growth
5 AMERICAS
5.1 Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Country
5.1.1 Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
5.1.2 Americas ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
5.2 Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
5.3 Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Region
6.1.1 APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024)
6.1.2 APAC ?-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024)
6.2 APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
6.3 APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe ?-Nicotinamide Mononucleotide (NMN) by Country
7.1.1 Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
7.1.2 Europe ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
7.2 Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
7.3 Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) by Country
8.1.1 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
8.1.2 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
8.2 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
8.3 Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of ?-Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of ?-Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of ?-Nicotinamide Mononucleotide (NMN)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 ?-Nicotinamide Mononucleotide (NMN) Distributors
11.3 ?-Nicotinamide Mononucleotide (NMN) Customer
12 WORLD FORECAST REVIEW FOR ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
12.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
12.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Forecast by Region (2025-2030)
12.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global ?-Nicotinamide Mononucleotide (NMN) Forecast by Type (2025-2030)
12.7 Global ?-Nicotinamide Mononucleotide (NMN) Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 GeneHarbor
13.1.1 GeneHarbor Company Information
13.1.2 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.1.3 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GeneHarbor Main Business Overview
13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
13.2.1 Herbalmax Company Information
13.2.2 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.2.3 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Herbalmax Main Business Overview
13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
13.3.1 Genex Formulas Company Information
13.3.2 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.3.3 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Genex Formulas Main Business Overview
13.3.5 Genex Formulas Latest Developments
13.4 Mirailab Bioscience
13.4.1 Mirailab Bioscience Company Information
13.4.2 Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.4.3 Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Mirailab Bioscience Main Business Overview
13.4.5 Mirailab Bioscience Latest Developments
13.5 Maac10 Formulas
13.5.1 Maac10 Formulas Company Information
13.5.2 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.5.3 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Maac10 Formulas Main Business Overview
13.5.5 Maac10 Formulas Latest Developments
13.6 EffePharm
13.6.1 EffePharm Company Information
13.6.2 EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.6.3 EffePharm ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 EffePharm Main Business Overview
13.6.5 EffePharm Latest Developments
13.7 Bontac
13.7.1 Bontac Company Information
13.7.2 Bontac ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.7.3 Bontac ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bontac Main Business Overview
13.7.5 Bontac Latest Developments
13.8 CELFULL
13.8.1 CELFULL Company Information
13.8.2 CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.8.3 CELFULL ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CELFULL Main Business Overview
13.8.5 CELFULL Latest Developments
13.9 Kingdomway
13.9.1 Kingdomway Company Information
13.9.2 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.9.3 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Kingdomway Main Business Overview
13.9.5 Kingdomway Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. ?-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. ?-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 6. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Table 7. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Type (2019-2024) & ($ million)
Table 8. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Table 9. Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024) & (US$/Kg)
Table 10. Global ?-Nicotinamide Mononucleotide (NMN) Sale by Application (2019-2024) & (Tons)
Table 11. Global ?-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
Table 12. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & ($ million)
Table 13. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2024)
Table 14. Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024) & (US$/Kg)
Table 15. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Company (2019-2024) & (Tons)
Table 16. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
Table 17. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024) & ($ millions)
Table 18. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
Table 19. Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Company (2019-2024) & (US$/Kg)
Table 20. Key Manufacturers ?-Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 21. Players ?-Nicotinamide Mononucleotide (NMN) Products Offered
Table 22. ?-Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2019-2024)
Table 27. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019-2024)
Table 31. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 34. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Table 35. Americas ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 37. Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 38. APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024) & (Tons)
Table 39. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2019-2024)
Table 40. APAC ?-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 42. APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 43. Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 44. Europe ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 46. Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of ?-Nicotinamide Mononucleotide (NMN)
Table 52. Key Market Challenges & Risks of ?-Nicotinamide Mononucleotide (NMN)
Table 53. Key Industry Trends of ?-Nicotinamide Mononucleotide (NMN)
Table 54. ?-Nicotinamide Mononucleotide (NMN) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. ?-Nicotinamide Mononucleotide (NMN) Distributors List
Table 57. ?-Nicotinamide Mononucleotide (NMN) Customer List
Table 58. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas ?-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC ?-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. GeneHarbor Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 73. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 74. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 75. GeneHarbor Main Business
Table 76. GeneHarbor Latest Developments
Table 77. Herbalmax Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 78. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 79. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 80. Herbalmax Main Business
Table 81. Herbalmax Latest Developments
Table 82. Genex Formulas Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 83. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 84. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 85. Genex Formulas Main Business
Table 86. Genex Formulas Latest Developments
Table 87. Mirailab Bioscience Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 88. Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 89. Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 90. Mirailab Bioscience Main Business
Table 91. Mirailab Bioscience Latest Developments
Table 92. Maac10 Formulas Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 93. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 94. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 95. Maac10 Formulas Main Business
Table 96. Maac10 Formulas Latest Developments
Table 97. EffePharm Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 98. EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 99. EffePharm ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 100. EffePharm Main Business
Table 101. EffePharm Latest Developments
Table 102. Bontac Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bontac ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 104. Bontac ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 105. Bontac Main Business
Table 106. Bontac Latest Developments
Table 107. CELFULL Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 108. CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 109. CELFULL ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 110. CELFULL Main Business
Table 111. CELFULL Latest Developments
Table 112. Kingdomway Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 113. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 114. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 115. Kingdomway Main Business
Table 116. Kingdomway Latest Developments
Table 1. ?-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. ?-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 6. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Table 7. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Type (2019-2024) & ($ million)
Table 8. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Table 9. Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024) & (US$/Kg)
Table 10. Global ?-Nicotinamide Mononucleotide (NMN) Sale by Application (2019-2024) & (Tons)
Table 11. Global ?-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
Table 12. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & ($ million)
Table 13. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2024)
Table 14. Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024) & (US$/Kg)
Table 15. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Company (2019-2024) & (Tons)
Table 16. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
Table 17. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024) & ($ millions)
Table 18. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
Table 19. Global ?-Nicotinamide Mononucleotide (NMN) Sale Price by Company (2019-2024) & (US$/Kg)
Table 20. Key Manufacturers ?-Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 21. Players ?-Nicotinamide Mononucleotide (NMN) Products Offered
Table 22. ?-Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2019-2024)
Table 27. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019-2024)
Table 31. Global ?-Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 34. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Table 35. Americas ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 37. Americas ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 38. APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024) & (Tons)
Table 39. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2019-2024)
Table 40. APAC ?-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 42. APAC ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 43. Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 44. Europe ?-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 46. Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of ?-Nicotinamide Mononucleotide (NMN)
Table 52. Key Market Challenges & Risks of ?-Nicotinamide Mononucleotide (NMN)
Table 53. Key Industry Trends of ?-Nicotinamide Mononucleotide (NMN)
Table 54. ?-Nicotinamide Mononucleotide (NMN) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. ?-Nicotinamide Mononucleotide (NMN) Distributors List
Table 57. ?-Nicotinamide Mononucleotide (NMN) Customer List
Table 58. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas ?-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC ?-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. GeneHarbor Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 73. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 74. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 75. GeneHarbor Main Business
Table 76. GeneHarbor Latest Developments
Table 77. Herbalmax Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 78. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 79. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 80. Herbalmax Main Business
Table 81. Herbalmax Latest Developments
Table 82. Genex Formulas Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 83. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 84. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 85. Genex Formulas Main Business
Table 86. Genex Formulas Latest Developments
Table 87. Mirailab Bioscience Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 88. Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 89. Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 90. Mirailab Bioscience Main Business
Table 91. Mirailab Bioscience Latest Developments
Table 92. Maac10 Formulas Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 93. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 94. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 95. Maac10 Formulas Main Business
Table 96. Maac10 Formulas Latest Developments
Table 97. EffePharm Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 98. EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 99. EffePharm ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 100. EffePharm Main Business
Table 101. EffePharm Latest Developments
Table 102. Bontac Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bontac ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 104. Bontac ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 105. Bontac Main Business
Table 106. Bontac Latest Developments
Table 107. CELFULL Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 108. CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 109. CELFULL ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 110. CELFULL Main Business
Table 111. CELFULL Latest Developments
Table 112. Kingdomway Basic Information, ?-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 113. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 114. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 115. Kingdomway Main Business
Table 116. Kingdomway Latest Developments
LIST OF FIGURES
Figure 1. Picture of ?-Nicotinamide Mononucleotide (NMN)
Figure 2. ?-Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global ?-Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. ?-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2023)
Figure 10. ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Content ?98%
Figure 12. Product Picture of Content ?98%
Figure 13. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2023
Figure 14. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Figure 15. ?-Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 16. Global ?-Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2019-2024) & (Tons)
Figure 17. ?-Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 18. Global ?-Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2019-2024) & (Tons)
Figure 19. ?-Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 20. Global ?-Nicotinamide Mononucleotide (NMN) Market: Others (2019-2024) & (Tons)
Figure 21. Global ?-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2023)
Figure 22. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2023
Figure 23. ?-Nicotinamide Mononucleotide (NMN) Sales by Company in 2023 (Tons)
Figure 24. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company in 2023
Figure 25. ?-Nicotinamide Mononucleotide (NMN) Revenue by Company in 2023 ($ millions)
Figure 26. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2023
Figure 27. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2023
Figure 29. Americas ?-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 30. Americas ?-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 31. APAC ?-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 32. APAC ?-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 33. Europe ?-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 34. Europe ?-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 36. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 37. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 38. Americas ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 39. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 40. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 41. United States ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2023
Figure 46. APAC ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2019-2024)
Figure 47. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 48. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 49. China ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 53. India ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 57. Europe ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 58. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 59. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 60. Germany ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 61. France ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 62. UK ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 68. Egypt ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of ?-Nicotinamide Mononucleotide (NMN) in 2023
Figure 74. Manufacturing Process Analysis of ?-Nicotinamide Mononucleotide (NMN)
Figure 75. Industry Chain Structure of ?-Nicotinamide Mononucleotide (NMN)
Figure 76. Channels of Distribution
Figure 77. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region (2025-2030)
Figure 78. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of ?-Nicotinamide Mononucleotide (NMN)
Figure 2. ?-Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global ?-Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. ?-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2023)
Figure 10. ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Content ?98%
Figure 12. Product Picture of Content ?98%
Figure 13. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2023
Figure 14. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Figure 15. ?-Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 16. Global ?-Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2019-2024) & (Tons)
Figure 17. ?-Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 18. Global ?-Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2019-2024) & (Tons)
Figure 19. ?-Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 20. Global ?-Nicotinamide Mononucleotide (NMN) Market: Others (2019-2024) & (Tons)
Figure 21. Global ?-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2023)
Figure 22. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2023
Figure 23. ?-Nicotinamide Mononucleotide (NMN) Sales by Company in 2023 (Tons)
Figure 24. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company in 2023
Figure 25. ?-Nicotinamide Mononucleotide (NMN) Revenue by Company in 2023 ($ millions)
Figure 26. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2023
Figure 27. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2023
Figure 29. Americas ?-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 30. Americas ?-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 31. APAC ?-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 32. APAC ?-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 33. Europe ?-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 34. Europe ?-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 36. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 37. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 38. Americas ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 39. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 40. Americas ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 41. United States ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2023
Figure 46. APAC ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2019-2024)
Figure 47. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 48. APAC ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 49. China ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 53. India ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 57. Europe ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 58. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 59. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 60. Germany ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 61. France ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 62. UK ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 68. Egypt ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries ?-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of ?-Nicotinamide Mononucleotide (NMN) in 2023
Figure 74. Manufacturing Process Analysis of ?-Nicotinamide Mononucleotide (NMN)
Figure 75. Industry Chain Structure of ?-Nicotinamide Mononucleotide (NMN)
Figure 76. Channels of Distribution
Figure 77. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region (2025-2030)
Figure 78. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2025-2030)
